Global Radiopharmaceuticals Market - 2020-2027

Market Overview

The Global Radiopharmaceuticals Market is expected to grow at a CAGR of 9.2% during the forecasting period (2019-2026).

Radiopharmaceuticals also known as Nuclear medicines are a group of pharmaceutical drugs which have radioactivity and can be used as diagnostic and therapeutic agents.

Radiopharmaceuticals emit radiation themselves, which is different from fluids within the body which absorb or alter external electromagnetism or ultrasound. This phenomenon helps to identify the various abnormalities such as cancer cells, within the human body.

Market Drivers and Restraints

Global radiopharmaceuticals market is growing at a steady pace and anticipated to exhibit similar faster growth in the future.

The market growth is attributed to driving factors such as improvements in diagnostic facilities, an increase in the number of new cancer cases, and an increase in preference for radiation therapy for cancer treatment.

Moreover, developments in imaging technologies using radiopharmaceuticals and alpha radioimmunotherapy-based targeted cancer treatment are also key factors fueling the growth of the market.

The global radiopharmaceuticals market might experience a hindrance in the growth owing to the short half-life of radiopharmaceuticals, supply-demand gap of the pharmaceuticals, and high equipment prices of diagnostic imaging devices.

Market Segementation

By End User

The Radiopharmaceuticals market is segmented on end user as Hospitals & Clinics, Diagnostic Centers, and Others. Diagnostic centers dominate the market share with more than 50% of the market share.

Other category includes primarily research centers which are driving the growth for Another end-user segment.

By geography

Based on the geography, North America is dominating the global Radiopharmaceuticals system market, and it is expected to grow in the forecast period.

The US is the most significant revenue contributor to this region because of an increase in the elderly population. Advances in technology in product, design, structure, and usage, development of various types of radiopharmaceuticals have contributed to the growth of the market in the US.

The Asia-pacific region is anticipated to be the fastest growing region in the global radiopharmaceuticals market. Technological innovations, growing elderly population, and improvements in healthcare infrastructure are the primary contributors to the growth of the market in Asia-Pacific.

Competitive Analysis

Several new players have entered into the global market for a radiopharmaceutical, and this trend denotes to the growing acceptance and popularity of dangerous drugs across the globe.

The market vendors that have earned a name for themselves in the global radiopharmaceuticals market have stuck to the basics of proper planning, marketing, and distribution of products. Established market vendors are recalibrating their business strategies to fit the needs and want of the consumers.

The distributors of dangerous drugs have also played a key role in reaching to wider audiences and expanding their consumer base. Product launch is one of the key strategy adopted by the principal manufacturers to improve their market presence across the globe.

For instance, In January 2018, Norgine B.V., a leading European specialty pharmaceutical company has announced the launch of LYMPHOSEEK® (Tc 99m tilmanocept) in Finland and Sweden. LYMPHOSEEK is a radiopharmaceutical used for diagnostic purposes by nuclear medicine specialists and surgeons.

Radio Pharmaceuticals Applications

1.Diagnostic Radioisotopes

Single-Photon Emission Computed Tomography (SPECT)

• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-23
• Others

Positron Emission Tomography

• Fluorine-18
• Rubidium-82
• Others

2.Therapeutic Radioisotopes

Beta Emitters

• Iodine-131
• Yttrium-90
• Rhenium-186
• Others

Alpha Emitters

• Brachytherapy
• Iodine-125
• Cesium-131
• Others

Reasons for purchasing this report?

• Visualize the composition of the Radiopharmaceuticals market across each indication, regarding by type, by application, and by end user highlighting the vital commercial assets and players.
• Identify business opportunities in Radiopharmaceuticals market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of the Radiopharmaceuticals market - level 4/5 segmentation
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
• Product mapping in excel for the Radiopharmaceuticals products of all major market players

Who can benefit from this report?

• Raw Material Suppliers/ Buyers
• Product Suppliers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturer

Table of Contents

1 Global Radiopharmaceuticals Market Methodology and Scope

• 1.1 Research methodology
• 1.2 Research Objective and Scope of the Report

2 Global Radiopharmaceuticals Market - Market Definition and Disease Overview

3 Global Radiopharmaceuticals Market - Executive Summary

• 3.1 Market Snippet by Radioisotopes
• 3.2 Market Snippet by Application
• 3.3 Market Snippet by Source
• 3.4 Market Snippet by Region
• 3.5 Market Snippet by End User

4 Global Radiopharmaceuticals Market - Market Dynamics

• 4.1 Market Impacting Factors
  • 4.1.1 Drivers
  • 4.1.2 Restraints
  • 4.1.3 Opportunity
  • 4.1.4 Impact Analysis

5 Global Radiopharmaceuticals Market - Industry Forces

• 5.1 Supply Chain Analysis
• 5.2 Pricing Analysis
• 5.3 Key Companies to Watch
• 5.4 Technology Development
• 5.5 Epidemiology

6 Global Radiopharmaceuticals Market - Market Dynamics

• 6.1 PEST Analysis
• 6.2 PORTERS Five Forces
• 6.3 Product Adoption Rate

7 Global Radiopharmaceuticals Market - By Radioisotopes

• 7.1 Introduction
• 7.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
• 7.3 Market Attractiveness Index, By Radioisotopes
  • 7.1.1 Tec.99*
    • 7.1.1.1 Introduction
    • 7.1.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
  • 7.1.2 F18
  • 7.1.3 Iodine 131
  • 7.1.4 Leutetium 177
  • 7.1.5 Yttrium 90
  • 7.1.6 Gallium 68
  • 7.1.7 Gallium 67
  • 7.1.8 Rubidium 82
  • 7.1.9 Iodine 123
  • 7.1.10 Iodine 125
  • 7.1.11 Indium 111
  • 7.1.12 Others

8 Global Radiopharmaceuticals Market - By Application

• 8.1 Introduction
• 8.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
• 8.3 Market Attractiveness Index, By Application
  • 8.3.1 Oncology*
    • 8.3.1.1 Introduction
    • 8.3.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
  • 8.3.2 Cardiology
  • 8.3.3 Gastroenterology
  • 8.3.4 Neuroendocrinology
  • 8.3.5 Neurology
  • 8.3.6 Nephrology
  • 8.3.7 Others

9 Global Radiopharmaceuticals Market - By Source

• 9.1 Introduction
• 9.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
• 9.3 Market Attractiveness Index, By Source
  • 9.3.1 Cyclotrons*
    • 9.3.1.1 Introduction
    • 9.3.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
  • 9.3.2 Nuclear Reactor

10 Global Radiopharmaceuticals Market - By End User

• 10.1 Introduction
• 10.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
• 10.3 Market Attractiveness Index, By End User
  • 10.3.1 Hospitals*
    • 10.3.1.1 Introduction
    • 10.3.1.2 Market Size Analysis, US$ Mn, 2017-2026 and Y-o-Y Growth Analysis (%), 2018-2026
  • 10.3.2 Diagnostic Imaging Centers
  • 10.3.3 Ambulatory Surgical Centers
  • 10.3.4 Cancer Research Institute

11 Global Radiopharmaceuticals Market - By Region

• 11.1 Introduction
• 11.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
• 11.3 Market Attractiveness Index, By Region
  • 11.1.1 North America
    • 11.1.1.1 Introduction
    • 11.1.1.2 Key Region-Specific Dynamics
    • 11.1.1.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
    • 11.1.1.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.1.1.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.1.1.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.1.1.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.1.1.1.1 U.S.A
    • 11.1.1.1.2 Canada
    • 11.1.1.1.3 Mexico
  • 11.1.2 South America
    • 11.1.2.1 Introduction
    • 11.1.2.2 Key Region-Specific Dynamics
    • 11.1.2.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
    • 11.1.2.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.1.2.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.1.2.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.1.2.1.1 Brazil
    • 11.1.2.1.2 Argentina
    • 11.1.2.1.3 Rest of South America
  • 11.1.3 Europe
    • 11.1.3.1 Introduction
    • 11.1.3.2 Key Region-Specific Dynamics
    • 11.1.3.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
    • 11.1.3.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.1.3.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.1.3.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.1.3.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.1.3.1.1 Germany
    • 11.1.3.1.2 U.K.
    • 11.1.3.1.3 France
    • 11.1.3.1.4 Italy
    • 11.1.3.1.5 Spain
    • 11.1.3.1.6 Russia
    • 11.1.3.1.7 Rest of Europe
  • 11.1.4 Asia Pacific
    • 11.1.4.1 Introductions
    • 11.1.4.2 Key Region-Specific Dynamics
    • 11.1.4.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
    • 11.1.4.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.1.4.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.1.4.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.1.4.7 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.1.4.1.1 China
    • 11.1.4.1.2 India
    • 11.1.4.1.3 Japan
    • 11.1.4.1.4 Australia
    • 11.1.4.1.5 South Korea
    • 11.1.4.1.6 Rest of Asia Pacific
  • 11.1.5 Middle East and Africa
    • 11.1.5.1 Introductions
    • 11.1.5.2 Key Region-Specific Dynamics
    • 11.1.5.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
    • 11.1.5.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.1.5.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
    • 11.1.5.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12 Global Radiopharmaceuticals Market - Competitive Landscape

• 12.1 Competitive Scenario
• 12.2 Competitor Strategy Analysis
• 12.3 Comparative Product Portfolio Analysis
• 12.4 Market Positioning/Share Analysis
• 12.5 Mergers and Acquisitions Analysis

13 Company Profiles

• 13.1 GE Healthcare*
  • 13.1.1 Company Overview
  • 13.1.2 Product Portfolio and Description
  • 13.1.3 Key Highlights
  • 13.1.4Financials Overview
• 13.2 Mallinckrodt PLC
• 13.3 Siemens Healthineers
• 13.4 Eckert & Ziegler
• 13.5 Lantheus Medical Imaging, Inc.
• 13.6 Cardinal Health, Inc.
• 13.7 Bayer AG
• 13.8 Bracco Imaging S.P.A
• 13.9 Nordion, Inc
• 13.10 Advanced Accelerator Applications S.A.
• 13.11 IBA Radiopharma Solutions
• 13.12 Fujifilm Holdings Corporation
• 13.13 Ion Beam Applications
• 13.14 NorthStar Medical Radioisotopes, LLC
• 13.15 Synektik Group
• 13.16 ABX GmbH
• 13.17 Coqui Radiopharmaceuticals
• 13.18 Tema Sinergie
• 13.19 Curium
• 13.20 Jubilant Pharma LLC
• 13.21 PET Pharm Biotech Co. Ltd
• 13.22 Isorad Ltd
• 13.23 Sirtex

14 Global Radiopharmaceuticals Market - Premium Analyst Insights

15 Global Radiopharmaceuticals Market - DataM

• 15.1 Abbreviations and Assumptions
• 15.2 About Us and Services
• 15.3 Contact Us